博晟生醫 (6733)
博晟生醫 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$21.39M, up 9.5% from a year earlier. EPS over the last four quarters totals -NT$0.54.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2021-01-28
- Founded
- 2016-07-07
- Paid-in capital
- NT$1.34B
- Common shares issued
- 134,316,026
- Legal name
- 博晟生醫股份有限公司
- Website
- https://www.biogend.com.tw/
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$21.39M | +10.9% | +9.5% |
| 2026-08 | NT$19.28M | -2.2% | +9.3% |
Year to date: +8.0% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | -0.18 |
| 2026 Q1 | -0.13 |
| 2025 Q4 | -0.18 |
| 2025 Q3 | -0.05 |
| 2025 Q2 | -0.19 |
| 2025 Q1 | -0.27 |
| 2024 Q4 | -0.32 |
| 2024 Q3 | -0.26 |
Last four quarters: -NT$0.54
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 795 | 0.1% |
| 1,000–5,000 shares | 4,286 | 6.6% |
| 5,001–10,000 shares | 834 | 4.9% |
| 10,001–15,000 shares | 341 | 3.3% |
| 15,001–20,000 shares | 236 | 3.2% |
| 20,001–30,000 shares | 245 | 4.6% |
| 30,001–40,000 shares | 107 | 2.8% |
| 40,001–50,000 shares | 89 | 3.0% |
| 50,001–100,000 shares | 183 | 9.7% |
| 100,001–200,000 shares | 66 | 6.8% |
| 200,001–400,000 shares | 32 | 6.2% |
| 400,001–600,000 shares | 10 | 3.7% |
| 600,001–800,000 shares | 7 | 3.5% |
| 800,001–1,000,000 shares | 2 | 1.2% |
| 1,000,001+ shares | 7 | 40.2% |
TDCC data for 2026-10-16: 7 holders own more than 1,000 lots (40.2% of shares), and 795 hold less than one lot (0.1%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -5 | 0 | 0 | -5 |
| 2026-10-16 | -8 | 0 | 0 | -8 |
| 2026-10-15 | 10 | 0 | 0 | 10 |
| 2026-10-14 | -3 | 0 | 0 | -3 |
| 2026-10-13 | 2 | 0 | 0 | 2 |
| 2026-10-12 | 10 | 0 | 0 | 10 |
| 2026-10-08 | 0 | 0 | 0 | 0 |
| 2026-10-07 | -5 | 0 | 0 | -5 |
| 2026-10-06 | -1 | 0 | 0 | -1 |
| 2026-10-05 | -52 | 0 | 0 | -52 |
| 2026-10-02 | -10 | 0 | 0 | -10 |
| 2026-10-01 | -7 | 0 | 0 | -7 |
| 2026-09-30 | -25 | 0 | 0 | -25 |
| 2026-09-29 | -11 | 0 | 0 | -11 |
| 2026-09-24 | -19 | 0 | 0 | -19 |
| 2026-09-23 | -16 | 0 | 0 | -16 |
| 2026-09-22 | -66 | 0 | 0 | -66 |
| 2026-09-21 | -25 | 0 | 0 | -25 |
| 2026-09-18 | -16 | 0 | 0 | -16 |
| 2026-09-17 | -1 | 0 | 0 | -1 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net sellers of 248 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$23.80 (2026-10-19); 52-week range NT$23.40–46.75.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.